Disclosure: This site earns commissions from affiliate links (Amazon, Etsy, and others) at no extra cost to you.   Full affiliate disclosure →

Updated July 2026 · 9 min read

This article was created with AI assistance.

Acute Ischemic Stroke & Thrombolytics: The ICU Nurse's Guide

⚕️ Medical Disclaimer: This content is for educational purposes only and is intended for licensed healthcare professionals. It does not constitute medical advice and should not replace clinical judgment, facility protocols, or physician orders. Always verify medications, doses, and procedures with your institution's guidelines.

Part of the ICU Emergencies Hub — browse every related guide in one place.

In an ischemic stroke, a clot has shut off blood flow to part of the brain and roughly two million neurons die every minute the vessel stays blocked. Everything the stroke team does is a race against that clock. The nurse is the person who documents the last-known-well time, runs the neuro checks that catch a deterioration, and manages the fragile window after a clot-busting drug goes into a brain that could just as easily bleed.

The short version: Acute ischemic stroke is time-is-brain. The workup confirms it is ischemic (not a bleed) with a non-contrast CT, establishes the last-known-well time, and screens for exclusions before giving a thrombolytic (alteplase/tPA or tenecteplase) within the treatment window. Large-vessel clots may also go for mechanical thrombectomy. After the lytic, the whole game is tight blood-pressure control, frequent neuro checks, and watching for intracranial bleeding.

Time is brain: the last-known-well clock

The single most important number in a stroke workup is not a lab value — it is the last-known-well (LKW) time: the last moment the patient was seen at their neurologic baseline. Thrombolytic eligibility is measured from LKW, not from when symptoms were discovered. A patient who wakes with deficits is timed from when they went to sleep well, which is why "wake-up strokes" are often outside the standard window unless advanced imaging reopens the door. When you take report or witness the onset, nail down that time and the source of it, because it drives every downstream decision.

Confirm it is ischemic before anything else

An ischemic stroke and a hemorrhagic stroke can look identical at the bedside, and the treatments are opposite — one gets a clot-buster, the other would be killed by it. So the first stop is a non-contrast head CT, whose main early job is to rule out hemorrhage. CT angiography then hunts for a large-vessel occlusion that a thrombectomy could pull. While imaging happens, the team is scoring the deficit with the NIH Stroke Scale (NIHSS), checking a glucose (hypoglycemia is a classic stroke mimic — always check it), and screening for the thrombolytic exclusions below.

Alteplase vs. tenecteplase

Two thrombolytics are used to dissolve the clot. Both convert plasminogen to plasmin to break down fibrin; the practical difference is how they are given.

AgentHow it is givenNotes
Alteplase (tPA)IV bolus then a 60-minute infusionThe long-standing standard; requires a dedicated pump and close watch through the drip.
Tenecteplase (TNK)Single IV bolusIncreasingly used in stroke; a single push is faster and simpler, especially before transfer for thrombectomy.

Dosing for stroke is weight-based and is not the same as the cardiac dosing of these drugs — a critical, oft-drilled safety point. Verify the stroke-specific dose and weight independently, because a decimal error here bleeds into the brain.

The stroke dose is not the heart-attack dose. Both alteplase and tenecteplase are also used for MI and PE at different doses. Confirm you are using the stroke protocol dose for the patient's actual weight, and have a second nurse verify.

Who cannot get the drug: the exclusion screen

Thrombolytics are dangerous in the wrong patient. The team screens a long list; the ones a nurse most often surfaces include:

ExclusionWhy
Any sign of hemorrhage on CTLysing into a bleed is catastrophic.
Recent surgery, major trauma, active internal bleeding, or recent strokeHigh bleeding risk.
Blood pressure above ~185/110 that cannot be safely loweredHigh post-lytic hemorrhage risk; must be controlled before the drug.
Anticoagulated / coagulopathy (elevated INR, therapeutic DOAC, low platelets)Compounded bleeding risk.
Blood glucose very low or very highHypoglycemia mimics stroke; extremes worsen risk.

These are relative and absolute in the actual protocol — the point for the bedside nurse is to have the labs, the pressure, and the history ready so the decision is not held up.

The blood-pressure tightrope

Blood-pressure management flips depending on whether the patient gets a lytic, and it is one of the most nurse-owned parts of stroke care.

Before a lytic: lower the pressure to under 185/110 so the drug can be given, typically with a titratable agent like labetalol or nicardipine.
After a lytic: keep it under about 180/105 for 24 hours to protect against hemorrhage — this is a hard ceiling you defend with frequent cuff or arterial-line checks.
If no lytic is given (ineligible): the team often tolerates a higher "permissive hypertension" to keep the ischemic penumbra perfused, lowering only very high pressures. The target is deliberately looser — do not aggressively normalize a pressure the brain is using to feed itself.

That last point trips people up: the same 190/100 that is an emergency to fix before tPA can be intentionally left alone in a patient who did not get tPA. The plan comes from the team and the eligibility, not from a single number.

After the drug: the post-lytic watch

Once the thrombolytic is in, the nurse runs a tight protocol built around one fear — intracranial hemorrhage. Typical elements:

A new headache, vomiting, worsening deficit, or a sudden pressure spike after tPA is an intracranial bleed until proven otherwise. Do not chart it and wait — this is a stop-and-call event. Reversal (cryoprecipitate, antifibrinolytics) and neurosurgery may be needed fast.

Angioedema and the airway

Alteplase can trigger orolingual angioedema — swelling of the tongue and lips, sometimes one-sided — usually early in the infusion. It is easy to miss because the patient may already have facial weakness. Keep looking at the mouth; a swelling tongue is an airway emergency that can require stopping the drug and calling for airway support.

Thrombectomy: the other reperfusion

For a large-vessel occlusion, mechanical thrombectomy — threading a catheter up to physically remove the clot — can be done in a longer window than IV lytics, sometimes up to 24 hours in selected patients guided by perfusion imaging. Many patients get the drug and go to the angio suite. Your role includes prepping for transfer, maintaining the pressure targets, and resuming intensive neuro monitoring afterward, watching both for reperfusion injury and for groin-site bleeding.

Bottom line

Ischemic stroke is a stopwatch. Fix the last-known-well time, get the CT that rules out a bleed, control the pressure to the eligibility window, and verify the stroke dose of alteplase or tenecteplase. Then the job becomes vigilance: frequent neuro checks, a hard blood-pressure ceiling, no new punctures, and treating any new headache, vomiting, or deficit as a hemorrhage until a scan says otherwise. For the pressure tools you will reach for, see our related pieces on managing subarachnoid hemorrhage and vasospasm and the ICP crisis in traumatic brain injury, and on status epilepticus, which can complicate any acute brain injury.

This article is general educational information for licensed clinicians and students, not medical advice or a substitute for your institution's protocols, pharmacy guidance, or a provider's orders. Always follow facility policy and verify doses independently.

Get the ICU Notebook

Free investing strategies built for nurses. One email per week, no fluff.

Yes, send it free

No spam. Unsubscribe any time.